Pure erythroid leukemia

Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing >80% of marrow cellularity, with ≥30% proerythroblasts. Pure erythroid leukemia is a rare and aggressive form of acut...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports 2020-12, Vol.8 (12), p.3598-3599
Main Authors: Forest, Méghan, Roy, Simon F., Houde, Michelle, Maietta, Antonio
Format: Article
Language:English
Subjects:
AML
Bone marrow
bone marrow pathology
Case reports
Clinical Image
Clinical Images
Conflicts of interest
hematological oncology
Leukemia
pancytopenia
pure erythroid leukemia
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4696-6504a70b55222250abba9b21c06fe4575cff00a682ec90b1ba57e54f4defd8483
container_end_page 3599
container_issue 12
container_start_page 3598
container_title Clinical case reports
container_volume 8
creator Forest, Méghan
Roy, Simon F.
Houde, Michelle
Maietta, Antonio
description Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing >80% of marrow cellularity, with ≥30% proerythroblasts. Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing >80% of marrow cellularity, with ≥30% proerythroblasts.
doi_str_mv 10.1002/ccr3.3316
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_bb2285d33bd14fc28912384bb86e9ce8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_bb2285d33bd14fc28912384bb86e9ce8</doaj_id><sourcerecordid>2473414848</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4696-6504a70b55222250abba9b21c06fe4575cff00a682ec90b1ba57e54f4defd8483</originalsourceid><addsrcrecordid>eNp1kUtLAzEURoMoWmoXrtyJ4EYXbW-eM9kIUnxBQRFdhyRzR6dOG810lP57p50qVjCbG5LD4eN-hBxQGFAANvQ-8gHnVG2RDgMJfdAgtn_d90ivqiYAQCFhksIu2eOcK6616pDD-zriMcbF_CWGIjsusX7FaWH3yU5uywp769klT1eXj6Ob_vju-nZ0Me57obTqKwnCJuCkZM2RYJ2z2jHqQeUoZCJ9ngNYlTL0Ghx1ViYoRS4yzLNUpLxLbltvFuzEvMViauPCBFuY1UOIz8bGeeFLNM4xlsqMc5dRkXuWasp4KpxLFWqPS9d563qr3RQzj7N5tOWGdPNnVryY5_BhkkQyrnQjOF0LYnivsZqbaVF5LEs7w1BXhomECyra3Cd_0Emo46xZlWFSJlTRdCU8aykfQ1VFzH_CUDDL9syyPbNsr2GPfqf_Ib-7aoBhC3wWJS7-N5nR6IGvlF_CIqEI</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2557161869</pqid></control><display><type>article</type><title>Pure erythroid leukemia</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>NCBI_PubMed Central（免费）</source><source>Publicly Available Content Database</source><creator>Forest, Méghan ; Roy, Simon F. ; Houde, Michelle ; Maietta, Antonio</creator><creatorcontrib>Forest, Méghan ; Roy, Simon F. ; Houde, Michelle ; Maietta, Antonio</creatorcontrib><description>Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing &gt;80% of marrow cellularity, with ≥30% proerythroblasts. Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing &gt;80% of marrow cellularity, with ≥30% proerythroblasts.</description><identifier>ISSN: 2050-0904</identifier><identifier>EISSN: 2050-0904</identifier><identifier>DOI: 10.1002/ccr3.3316</identifier><identifier>PMID: 33363996</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>AML ; Bone marrow ; bone marrow pathology ; Case reports ; Clinical Image ; Clinical Images ; Conflicts of interest ; hematological oncology ; Leukemia ; pancytopenia ; pure erythroid leukemia</subject><ispartof>Clinical case reports, 2020-12, Vol.8 (12), p.3598-3599</ispartof><rights>2020 The Authors. published by John Wiley &amp; Sons Ltd</rights><rights>2020 The Authors. Clinical Case Reports published by John Wiley &amp; Sons Ltd.</rights><rights>2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4696-6504a70b55222250abba9b21c06fe4575cff00a682ec90b1ba57e54f4defd8483</cites><orcidid>0000-0002-9638-3354</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2557161869/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2557161869?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11560,25751,27922,27923,37010,37011,44588,46050,46474,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33363996$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Forest, Méghan</creatorcontrib><creatorcontrib>Roy, Simon F.</creatorcontrib><creatorcontrib>Houde, Michelle</creatorcontrib><creatorcontrib>Maietta, Antonio</creatorcontrib><title>Pure erythroid leukemia</title><title>Clinical case reports</title><addtitle>Clin Case Rep</addtitle><description>Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing &gt;80% of marrow cellularity, with ≥30% proerythroblasts. Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing &gt;80% of marrow cellularity, with ≥30% proerythroblasts.</description><subject>AML</subject><subject>Bone marrow</subject><subject>bone marrow pathology</subject><subject>Case reports</subject><subject>Clinical Image</subject><subject>Clinical Images</subject><subject>Conflicts of interest</subject><subject>hematological oncology</subject><subject>Leukemia</subject><subject>pancytopenia</subject><subject>pure erythroid leukemia</subject><issn>2050-0904</issn><issn>2050-0904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kUtLAzEURoMoWmoXrtyJ4EYXbW-eM9kIUnxBQRFdhyRzR6dOG810lP57p50qVjCbG5LD4eN-hBxQGFAANvQ-8gHnVG2RDgMJfdAgtn_d90ivqiYAQCFhksIu2eOcK6616pDD-zriMcbF_CWGIjsusX7FaWH3yU5uywp769klT1eXj6Ob_vju-nZ0Me57obTqKwnCJuCkZM2RYJ2z2jHqQeUoZCJ9ngNYlTL0Ghx1ViYoRS4yzLNUpLxLbltvFuzEvMViauPCBFuY1UOIz8bGeeFLNM4xlsqMc5dRkXuWasp4KpxLFWqPS9d563qr3RQzj7N5tOWGdPNnVryY5_BhkkQyrnQjOF0LYnivsZqbaVF5LEs7w1BXhomECyra3Cd_0Emo46xZlWFSJlTRdCU8aykfQ1VFzH_CUDDL9syyPbNsr2GPfqf_Ib-7aoBhC3wWJS7-N5nR6IGvlF_CIqEI</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Forest, Méghan</creator><creator>Roy, Simon F.</creator><creator>Houde, Michelle</creator><creator>Maietta, Antonio</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9638-3354</orcidid></search><sort><creationdate>202012</creationdate><title>Pure erythroid leukemia</title><author>Forest, Méghan ; Roy, Simon F. ; Houde, Michelle ; Maietta, Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4696-6504a70b55222250abba9b21c06fe4575cff00a682ec90b1ba57e54f4defd8483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>AML</topic><topic>Bone marrow</topic><topic>bone marrow pathology</topic><topic>Case reports</topic><topic>Clinical Image</topic><topic>Clinical Images</topic><topic>Conflicts of interest</topic><topic>hematological oncology</topic><topic>Leukemia</topic><topic>pancytopenia</topic><topic>pure erythroid leukemia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Forest, Méghan</creatorcontrib><creatorcontrib>Roy, Simon F.</creatorcontrib><creatorcontrib>Houde, Michelle</creatorcontrib><creatorcontrib>Maietta, Antonio</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Online Library Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Forest, Méghan</au><au>Roy, Simon F.</au><au>Houde, Michelle</au><au>Maietta, Antonio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pure erythroid leukemia</atitle><jtitle>Clinical case reports</jtitle><addtitle>Clin Case Rep</addtitle><date>2020-12</date><risdate>2020</risdate><volume>8</volume><issue>12</issue><spage>3598</spage><epage>3599</epage><pages>3598-3599</pages><issn>2050-0904</issn><eissn>2050-0904</eissn><abstract>Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing &gt;80% of marrow cellularity, with ≥30% proerythroblasts. Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing &gt;80% of marrow cellularity, with ≥30% proerythroblasts.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>33363996</pmid><doi>10.1002/ccr3.3316</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-9638-3354</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2050-0904
ispartof Clinical case reports, 2020-12, Vol.8 (12), p.3598-3599
issn 2050-0904
2050-0904
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_bb2285d33bd14fc28912384bb86e9ce8
source Open Access: Wiley-Blackwell Open Access Journals; NCBI_PubMed Central（免费）; Publicly Available Content Database
subjects AML
Bone marrow
bone marrow pathology
Case reports
Clinical Image
Clinical Images
Conflicts of interest
hematological oncology
Leukemia
pancytopenia
pure erythroid leukemia
title Pure erythroid leukemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A41%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pure%20erythroid%20leukemia&rft.jtitle=Clinical%20case%20reports&rft.au=Forest,%20M%C3%A9ghan&rft.date=2020-12&rft.volume=8&rft.issue=12&rft.spage=3598&rft.epage=3599&rft.pages=3598-3599&rft.issn=2050-0904&rft.eissn=2050-0904&rft_id=info:doi/10.1002/ccr3.3316&rft_dat=%3Cproquest_doaj_%3E2473414848%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4696-6504a70b55222250abba9b21c06fe4575cff00a682ec90b1ba57e54f4defd8483%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2557161869&rft_id=info:pmid/33363996&rfr_iscdi=true